1. Home
  2. PFO vs ONCY Comparison

PFO vs ONCY Comparison

Compare PFO & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Flaherty & Crumrine Preferred and Income Opportunity Fund Incorporated

PFO

Flaherty & Crumrine Preferred and Income Opportunity Fund Incorporated

HOLD

Current Price

$8.87

Market Cap

118.6M

Sector

Finance

ML Signal

HOLD

Logo Oncolytics Biotech Inc.

ONCY

Oncolytics Biotech Inc.

HOLD

Current Price

$0.77

Market Cap

109.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PFO
ONCY
Founded
1991
1998
Country
United States
Canada
Employees
N/A
N/A
Industry
Finance Companies
Pharmaceuticals and Biotechnology
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
118.6M
109.1M
IPO Year
N/A
2002

Fundamental Metrics

Financial Performance
Metric
PFO
ONCY
Price
$8.87
$0.77
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$7.33
AVG Volume (30 Days)
22.5K
780.8K
Earning Date
01-01-0001
05-08-2026
Dividend Yield
6.51%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$2,505.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.80
$0.73
52 Week High
$9.90
$1.51

Technical Indicators

Market Signals
Indicator
PFO
ONCY
Relative Strength Index (RSI) 36.33 42.32
Support Level $8.85 $0.77
Resistance Level $9.23 $0.89
Average True Range (ATR) 0.05 0.05
MACD -0.01 -0.01
Stochastic Oscillator 27.59 22.64

Price Performance

Historical Comparison
PFO
ONCY

About PFO Flaherty & Crumrine Preferred and Income Opportunity Fund Incorporated

Flaherty & Crumrine Prfd Income Oppo is the United States-based diversified, closed-end management investment company. Its primary investment objective is to provide its common shareholders with high current income consistent with the preservation of capital. The fund invests in a diversified portfolio of preferred securities which includes traditional preferred stocks eligible for the inter-corporate dividends received a deduction and fully taxable preferred securities.

About ONCY Oncolytics Biotech Inc.

Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer, among others.

Share on Social Networks: